Romidepsin Versus Combination of Romidepsin Plus Pralatrexate in PTCL

Clinical trial NCT03355768 · WITHDRAWN

Trial details

NCT number: NCT03355768
Sponsor: Jennifer Amengual
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Lymphoma, T-Cell, Peripheral

Start date: 2018-09-01
Primary completion: 2018-11-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.